Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Type 2 diabetes mellitus (DM2) affects a 13.8% of the Spanish population1 and its prevalence is expected to increase in the future.2 The presence of DM2 increases significantly the risk of cardiovascular events, chronic kidney disease (CKD), and premature death3,4 and as its prevalence increases it is expected to rise the incidence of microvascular and macrovascular complications.5 Until the last decade, the control of blood glucose, blood pressure, dyslipidemia, and the use of inhibitors of the renin-angiotensin system (iSRA) have been the only strategies available to reduce cardiovascular and renal risk in this population
In this case, the target was a novel IGF-1, a protein important for bone and muscle health
TRACE prepares you with the knowledge and confidence to self-administer injections properly and provides everything you need to get started, including syringes, needles, alcohol swabs, and a convenient vial dispenser that helps you dose accurately and avoid waste
Understanding these distinctions helps patients make informed decisions with provider guidance
